A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib

Objective: To mine the adverse drug event (ADE) signals of upadacitinib based on the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database to provide a reference for the safe clinical use of the drug. Methods: The ADE data for upadacitinib from Q1 2004 to Q1 2023 in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yan, Wei, Meihao, Zhang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469920/
https://www.ncbi.nlm.nih.gov/pubmed/37663269
http://dx.doi.org/10.3389/fphar.2023.1200254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469920/
https://www.ncbi.nlm.nih.gov/pubmed/37663269
http://dx.doi.org/10.3389/fphar.2023.1200254

Ejemplares similares